Welcome to our dedicated page for Medical Prop SEC filings (Ticker: MPW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Medical Properties Trust, Inc. (NYSE: MPW) SEC filings page provides access to the company’s official regulatory disclosures as a self-advised real estate investment trust focused on net-leased hospital facilities. Formed in 2003 and incorporated in Maryland, Medical Properties Trust files reports and current disclosures with the U.S. Securities and Exchange Commission in connection with its common stock listed on the New York Stock Exchange under the symbol MPW.
Through this page, users can review key filings such as Form 10-K annual reports, which typically include detailed information on the company’s healthcare real estate portfolio, general acute, behavioral health and post-acute facilities, geographic exposure across the United States and international markets, capital structure, risk factors and management’s discussion and analysis. Form 10-Q quarterly reports provide interim updates on revenues from rent billed, straight-line rent, income from financing leases, interest and other income, as well as expenses, impairment charges, joint venture performance and balance sheet changes.
Investors can also examine Form 8-K current reports, where Medical Properties Trust discloses material events such as quarterly earnings releases, approval of a stock repurchase program, and other significant corporate actions. For example, Form 8-K filings in 2025 reference press releases announcing financial results for specific quarters and the authorization of a common stock repurchase program. In addition, filings may include exhibits with supplemental information packages and investor presentations.
Alongside traditional document access, this page highlights AI-powered tools that summarize lengthy filings, explain complex sections and surface important items such as changes in rent collections, impairment charges, financing transactions and capital allocation decisions. Users can quickly identify relevant sections of 10-Ks, 10-Qs and 8-Ks, and track how Medical Properties Trust reports on its hospital real estate portfolio, debt profile and shareholder-related actions over time.
Medical Properties Trust, Inc. director Steven G. Dawson reported receiving 30,303 shares of common stock on January 8, 2026. The shares were acquired at a price of $0, indicating they are an equity award rather than an open-market purchase. After this grant, Dawson directly holds 194,520 shares of common stock.
According to the filing, these 30,303 shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026. In addition to his direct holdings, the report shows 10,000 shares held indirectly through his spouse's 401(k) and 13,138 shares held indirectly as trustee for the Dawson Interest Pension Plan.
Medical Properties Trust Inc. director Elizabeth N. Pitman reported acquiring 30,303 shares of the company’s common stock on January 8, 2026, at a price of $0 per share. These shares vest in equal installments at the beginning of each of the 12 calendar quarters starting April 1, 2026, meaning they will be earned gradually over three years. After this award, she beneficially owns 130,898 shares of Medical Properties Trust common stock held directly.
Medical Properties Trust (MPW) director Daniel Paul Sparks reported an equity award of 30,303 shares of common stock on January 8, 2026. The award was recorded at a price of $0 per share, indicating it is a stock-based compensation grant rather than an open‑market purchase.
After this grant, Sparks beneficially owns 150,546 shares of Medical Properties Trust common stock in direct form. According to the footnote, these shares vest in equal installments at the beginning of each of the 12 calendar quarters starting on April 1, 2026, meaning the award will become fully vested over a three‑year period if service-based conditions are met.
Medical Properties Trust director Mozingo Caterina Ardon reported acquiring 30,303 shares of common stock on January 8, 2026 at a price of $0 per share, indicating a stock-based award rather than an open-market purchase. Following this transaction, she directly holds 110,468 shares of Medical Properties Trust common stock. According to the filing, these shares vest ratably at the beginning of each of the 12 calendar quarters starting on April 1, 2026, meaning the award is spread over three years of service.
Medical Properties Trust executive reports tax-related share withholding. SVP of Finance and Treasurer Charles R. Lambert had 2,836 shares of common stock withheld on January 9, 2026 at $5.04 per share in connection with the vesting of restricted stock, solely to cover tax obligations. According to the disclosure, this is not treated as a sale transaction. After this withholding, he beneficially owns 317,401 shares of Medical Properties Trust common stock directly.
Medical Properties Trust SVP of Operations Williams Rosa Handley reported an automatic share withholding tied to equity compensation. On January 9, 2026, 6,158 shares of common stock were withheld at $5.04 per share to cover tax obligations upon the vesting of restricted stock. The filing notes that this is not a sale transaction in the market. After this tax withholding event, Handley beneficially owned 389,024 shares of Medical Properties Trust common stock directly.
Medical Properties Trust Inc. senior vice president and senior advisor to the CEO, Larry H. Portal, reported an automatic share withholding tied to equity compensation. On January 9, 2026, 11,067 shares of common stock were withheld at $5.04 per share to cover tax obligations arising from the vesting of restricted stock. The filing states this withholding "does not constitute a sale transaction," meaning it was not an open-market sale. After this adjustment, Portal beneficially owned 470,624 shares of Medical Properties Trust common stock in direct ownership.
Medical Properties Trust insider reports tax withholding on vested stock. Senior VP, Controller & CAO James Kevin Hanna reported that on January 9, 2026, 9,274 shares of Medical Properties Trust common stock were withheld upon vesting of restricted stock to cover tax obligations at a reference price of $5.04 per share. The filing specifies this is not a sale transaction. After this withholding, Hanna directly holds 434,294 shares of the company’s common stock.
Medical Properties Trust executive Steven R. Hamner, Executive Vice President and CFO, reported equity award activity in the company’s common stock. On January 8, 2026, he was granted 509,124 shares tied to performance goals for debt reduction and cash revenue growth from January 1, 2026 through December 31, 2028, and 549,854 restricted shares that will vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. On January 9, 2026, 67,265 shares were withheld at $5.04 per share to satisfy tax obligations upon vesting of restricted stock, which is described as not constituting a sale. After these transactions, Hamner directly beneficially owned 3,889,568 shares of Medical Properties Trust common stock.
Medical Properties Trust Chairman, President & CEO Edward K. Aldag Jr. reported several stock-related transactions. On January 8, 2026, he was granted 1,018,247 shares of common stock that will be earned only if specific performance thresholds for reducing overall debt and growing cash revenue are met from January 1, 2026 through December 31, 2028, with a chance to earn up to one third based on 2026 results and further adjustment based on total shareholder return. The same day he also received 1,099,707 shares of common stock that vest in equal installments at the beginning of each of 12 calendar quarters starting April 1, 2026. On January 9, 2026, 188,951 shares were withheld at $5.04 per share to cover tax obligations upon vesting of restricted stock, which is not treated as a sale. After these transactions, he directly beneficially owns 6,904,641 shares of common stock.